CASEY M MEEKS
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner MURFREESBORO, TN NPI 1013300045
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner TN E.R. Squibb & Sons, L.L.C. All categories
General Payments — all program years on this page
$4,119.15
- Category: General Payments
- Program years: PY2021–2024
- Record count: 153
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $952.79 across 40 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $952.79 | 40 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $93.91 | 2 |
| EISAI INC. | $74.96 | 3 |
| Acerta Pharma LLC | $69.77 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $63.78 | 2 |
| Celgene Corporation | $50.54 | 2 |
| Janssen Biotech, Inc. | $46.48 | 2 |
| Daiichi Sankyo Inc. | $46.19 | 2 |
| AVEO Pharmaceuticals, Inc. | $35.69 | 1 |
| ABBVIE INC. | $32.25 | 2 |
| Ipsen Biopharmaceuticals, Inc | $30.17 | 1 |
| Regeneron Healthcare Solutions, Inc. | $29.49 | 1 |
| GENZYME CORPORATION | $25.00 | 1 |
| Blueprint Medicines Corporation | $24.53 | 1 |
| Gilead Sciences, Inc. | $23.32 | 1 |
| ADC Therapeutics America, Inc. | $22.14 | 1 |
| EMD Serono, Inc. | $22.04 | 1 |
| Deciphera Pharmaceuticals Inc. | $21.94 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $21.56 | 1 |
| Lilly USA, LLC | $21.36 | 1 |
| Exelixis Inc. | $20.31 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.24 | 1 |
| PFIZER INC. | $19.90 | 1 |
| Karyopharm Therapeutics Inc. | $19.68 | 1 |
| BeiGene USA, Inc. | $19.05 | 1 |
| GlaxoSmithKline, LLC. | $17.89 | 1 |
| TerSera Therapeutics LLC | $17.29 | 1 |
| ARRAY BIOPHARMA INC | $17.26 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $16.61 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.58 | 1 |
| TAIHO ONCOLOGY, INC. | $13.86 | 1 |
By program year
Records — PY2024 (40)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.